Compare AFRM & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AFRM | HSIC |
|---|---|---|
| Founded | 2012 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.6B | 9.6B |
| IPO Year | 2020 | 1996 |
| Metric | AFRM | HSIC |
|---|---|---|
| Price | $46.71 | $81.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 29 | 14 |
| Target Price | $83.65 | ★ $84.50 |
| AVG Volume (30 Days) | ★ 7.6M | 1.5M |
| Earning Date | 05-07-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 108.98 | 7.21 |
| EPS | 0.60 | ★ 3.27 |
| Revenue | $3,224,412,000.00 | ★ $13,201,995,000.00 |
| Revenue This Year | $30.35 | $4.70 |
| Revenue Next Year | $24.53 | $3.77 |
| P/E Ratio | $78.06 | ★ $25.27 |
| Revenue Growth | ★ 38.80 | 5.94 |
| 52 Week Low | $30.90 | $60.56 |
| 52 Week High | $100.00 | $89.29 |
| Indicator | AFRM | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 29.40 | 58.16 |
| Support Level | $45.54 | $74.66 |
| Resistance Level | $79.27 | $82.80 |
| Average True Range (ATR) | 3.17 | 2.66 |
| MACD | -0.01 | 0.33 |
| Stochastic Oscillator | 8.59 | 43.22 |
Founded in 2012, Affirm is a market leader in the buy-now, pay-later space with around $36 billion in transaction volume in fiscal 2025. Affirm offers both zero-interest financing, which is merchant subsidized, and interest-bearing loans, which function as personal loans that are approved on a per-transaction basis. Over 70% of Affirm's transaction volume comes from its interest-bearing loans, which also comprise the majority of its revenue. Affirm primarily operates in the United States, which accounted for more than 95% of its revenue in 2025, but the firm has also expanded to Canada and the United Kingdom.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.